Humira is the world’s most profitable drug, but it’s also a prime example of Big Pharma's business model, as Sy Mukherjee lays out well in a big Fortune story.
The big picture: "These companies became like great big record labels: reliant on talent spotters going out and finding new artists," SVB Leerink analyst Geoffrey Porges tells Fortune.